Differential diagnosis of hypoglycemia

Česká verzia

Authors: Jan Schovánek ¹; Ubica Cibičková ¹; Filip Čtvrtlík ²; Zdeněk Fryšák ¹; David Karásek ¹
Authors place of work: III. interní klinika – nefrologická, revmatologická a endokrinologická, Fakultní nemocnice Olomouc, a Lékařská fakulta Univerzity Palackého v Olomouci ¹; Radiologická klinika, Fakultní nemocnice Olomouc a Lékařská fakulta Univerzity Palackého v Olomouci ²
Published in the journal: Vnitř Lék 2020; 66(2): 129-133
Category: Differential Diagnosis Column or What You Can Be Asked at a Postgraduate Certification Exam

Summary

Our review summarizes the possible differential diagnoses of hypoglycemia. It confirms the absolute necessity of fulfilling all the three Whipple hypoglycemia criteria. Briefly is mentioned Clinical symptoms of hypoglycemia are briefly mentioned and several ways to classify the hypoglycemic events are offered. Highlighted is the recommended approach to distinguish patients as seemingly ill and healthy and also as hypoglycemia occurring in diabetic and non-diabetic. All the classifications and recommendations are summarized in attached tables and schemes.

Keywords:

hypoglycemia – tumor related hypoglycemia – Whipple trias

Zdroje

1. Surgery ISo. Journal International de Chirurgie1938.

2. Cryer PE. Hypoglycemia, functional brain failure, and brain death. The Journal of clinical investigation. 2007;117(4):868-70. Epub 2007/04/04.

3. Placzkowski KA, Vella A, Thompson GB, Grant CS, Reading CC, Charboneau JW, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987–2007. The Journal of clinical endocrinology and metabolism. 2009; 94(4): 1069–1073. Epub 2009/01/15.

4. Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Prac‑ tice Guideline. The Journal of clinical endocrinology and metabolism. 2009; 94(3): 709– 728. Epub 2008/12/18.

5. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo‑Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. The Journal of clinical endocrinology and metabolism. 2013; 98(5): 1845– 1859. Epub 2013/04/17.

6. Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes care. 2017; 40(1): 155–157. Epub 2016/11/23.

7. Nirantharakumar K, Marshall T, Hodson J, Narendran P, Deeks J, Coleman JJ, et al. Hypoglycemia in non‑diabetic in‑patients: clinical or criminal? PloS one. 2012; 7(7): e40384. Epub 2012/07/07.

8. Service FJ, Cryer PE, Vella A. Hypoglycemia in adults without diabetes mellitus: Clinical manifestations, diagnosis, and causes. UpToDate, Waltham, MA. (Accessed on June 13, 2019): UpToDate; 2019.

9. Dungan K, Merrill J, Long C, Binkley P. Effect of beta blocker use and type on hypoglycemia risk among hospitalized insulin requiring patients. Cardiovascular diabetology. 2019; 18(1): 163. Epub 2019/11/30.

10. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and out‑comes. Critical care medicine. 2007; 35(10): 2262–2267. Epub 2007/08/25.

11. Skrha J. Hypoglykemie : od patofyziologie ke klinické praxi. Praha: Maxdorf; 2013.

12. Bornstein SR, Allolio B, Arlt W, Barthel A, Don‑Wauchope A, Hammer GD, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2016; 101(2): 364– 389. Epub 2016/01/14.

13. Schovanek J, Cibickova L, Ctvrtlik F, Tudos Z, Karasek D, Iacobone M, et al. Hypoglycemia as a Symptom of Neoplastic Disease, with a focus on Insulin‑like Growth Factors Producing Tumors. Journal of Cancer. 2019; 10(26): 6475–6480. Epub 2019/11/30.

14. Service FJ, Vella A. Insulinoma. In: Post T, editor. UpToDate. UpToDate, Waltham, MA. (Accessed on July 19, 2018)2018.

15. de Groot JW, Rikhof B, van Doorn J, Bilo HJ, Alleman MA, Honkoop AH, et al. Non‑islet cell tumour‑induced hypoglycaemia: a review of the literature including two new cases. Endocrine‑related cancer. 2007; 14(4): 979–993. Epub 2007/11/30.

16. Wiesner TD, Bluher M, Windgassen M, Paschke R. Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. The Journal of clinical endocrinology and metabolism. 2003; 88(8): 3632–3636. Epub 2003/08/14.

17. Cerasi E, Effendic S, Luft R. Role of adrenergic receptors in glucose‑induced insulin secretion in man. Lancet. 1969; 2(7615): 301–302. Epub 1969/08/09.

18. Iglesias P, Diez JJ. Management of endocrine disease: a clinical update on tumor‑induced hypoglycemia. European journal of endocrinology. 2014; 170(4): R147–157. Epub 2014/01/25.

19. Service FJ, Vella A, Hirsch IB, Mulder JE. Nonislet cell tumor hypoglycemia. UpToDate, Waltham, MA. (Accessed on June 13, 2019): UpToDate; 2018.

20. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo‑Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes care. 2013; 36(5): 1384–1395. Epub 2013/04/17.